Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 601–700 of 1,012
Morrow, C. S., Peklak-Scott, C., Bishwokarma, B., Kute, T. E., Smitherman, P. K., & Townsend, A. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017988 · Cited by 116
“In addition, DNA sequence analysis revealed that the mRNA expressed in MCF7/VP cells encoded the common MRP1 variant (Cole et al., 1992), which at A SPE T Journals on July 19, 2018 m olpharm .aspetjournals.org D ow nloaded from is also identical to that encoded by the cDNA used to generate the…”
BackgroundMethodSoto‐Cerrato, V., Llagostera, E., Montaner, B., Scheffer, G. L., & Pérez‐Tomás, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.056 · Cited by 105
Filipits, M., Pohl, G., Rudas, M., Dietze, O., Lax, S., Grill, R., Pirker, R., Zielinski, C. C., Hausmaninger, H., Kubista, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.033 · Cited by 104
“The multidrug resistance protein 1 (MRP1), also called ABCC1, is another member of the ABC transporter family.(4) Overexpression of this protein in tumor cells confers resistance to various anticancer drugs, such as anthracyclines or methotrexate,(4-7) which are drugs that are part of the chemotherapy regimens current…”
Backgroundvan der Kolk, D. M., de Vries, E. G. E., Putten, W. J. V., Verdonck, L. F., Ossenkoppele, G. J., Verhoef, G. E. G., & Vellenga, E. (2000) · PubMed · Cited by 118
Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death
Larsen, A. K., & Składanowski, A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00140-7 · Cited by 126
Ross, D., Wooten, P., Sridhara, R. N., Ordóñez, J. V., Lee, E., & Schiffer, C. (1993) · Blood · doi:10.1182/blood.v82.4.1288.1288 · Cited by 105
Sosnik, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.002 · Cited by 111
“P-glycoprotein (P-gp, ABCB1,MDR1)was the first ever identified ABC [33,34], followed by the multidrug resistance-associated protein-1 (MRP-1, ABCC1) [35,36] and the breast cancer resistance protein (BCRP, ABCG2) [37,38].”
BackgroundInfluentialPark, H., Park, W., & Na, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.063 · Cited by 103
He, X., Ee, P. L. R., Coon, J. S., & Beck, W. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0439 · Cited by 121
Masui, K., Gini, B., Wykosky, J., Zanca, C., Mischel, P. S., Furnari, F. B., & Cavenee, W. K. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt086 · Cited by 128
“Overexpression of p-glycoprotein/ MDR1 and other adenosine triphosphate-binding cassette drug transporter genes, such as MRP1 and BCRP, have been shown to be associated with resistance in vitro (32) and clinically with poor response to therapy and shorter overall patient survival (33,34).”
BackgroundMultiple Splicing Variants of Two New Human ATP-Binding Cassette Transporters, ABCC11 and ABCC12
Yabuuchi, H., Shimizu, H., Takayanagi, S., & Ishikawa, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5865 · Cited by 124
Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer
Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyama, Y., Takagi, K., Ogata, T., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.372 · Cited by 117
Transport routes of metalloids into and out of the cell: A review of the current knowledge
Zangi, R., & Filella, M. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.02.001 · Cited by 111
“Resistance against arsenic and antimony has been observed in Leishmania [100,102] due to the PGPA transporter and in human cancer cells due to P-glycoprotein and a 190 kDa MRP transporter [103,104].”
BackgroundHarbottle, A., Daly, A. K., Atherton, K. M., & Campbell, F. C. (2001) · International Journal of Cancer · doi:10.1002/ijc.1283 · Cited by 112
Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia
Filipits, M., Pohl, G., Stranzl, T., Suchomel, R. W., Scheper, R. J., Jäger, U., Geissler, K. H., Lechner, K., & Pirker, R. (1998) · Blood · doi:10.1182/blood.v91.5.1508 · Cited by 103
Hanssen, K. M., Haber, M., & Fletcher, J. I. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100795 · Cited by 102
Mollaei, M., Hassan, Z. M., Khorshidi, F., & Langroudi, L. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101056 · Cited by 129
Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines
Liang, B. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00182138 · Cited by 102
“protein gene (MRP) [5], 06-alkylguanine DNA alkyltransferase gene (06MT) [6] and excision repair cross complementing gene 1 (ERCC1) [7, 8], which are associated with drug resistance and allow tumor cells to escape cell kill, even at high drug doses.”
BackgroundThe Candida albicans CDR3 gene codes for an opaque-phase ABC transporter
Balan, I., Alarco, A. M., & Raymond, M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.23.7210-7218.1997 · Cited by 102
“The MDR strain LSPQ 5902 was also included in these experiments as a positive control.”
BackgroundInfluentialTanaka, T., Uchiumi, T., Hinoshita, E., Inokuchi, A., Toh, S., Wada, M., Takano, H., Kohno, K., & Kuwano, M. (1999) · Hepatology · doi:10.1002/hep.510300617 · Cited by 101
Proton pump inhibitor‐induced tumour cell death by inhibition of a detoxification mechanism
Fais, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02225.x · Cited by 113
Sun, C., Suresh, A., Deng, Y.-Z., & Naqvi, N. I. (2006) · The Plant Cell Online · doi:10.1105/tpc.105.037861 · Cited by 107
“Several MDR-type P-glycoproteins have been shown to catalyze the ATP-dependent efflux of antitumor agents during chemotherapy of cancer cells (Cole et al., 1992; Gottesman and Pastan, 1993).”
BackgroundSeitz, S., Kretz-Rommel, A., Oude Elferink, R. P. J., & Boelsterli, U. A. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970203+ · Cited by 101
Homolya, L., Holló, M., Müller, M. M., Eb, M., & Sarkadi, B. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.151 · Cited by 101
[10] Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease
Taglicht, D., & Michaelis, S. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)92012-2 · Cited by 111
Pharmacokinetics of Dietary Phenethyl Isothiocyanate in Rats
Ji, Y., Kuo, Y., & Morris, M. E. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7097-z · Cited by 112
“MRP1 relies on the energy from ATP hydrolysis to efflux various anticancer drugs and toxins and is present ubiquitously in the human body and tumors including both solid tumors and hematological malignancies (29,30).”
BackgroundChloroquine resistance in the malarial parasite, Plasmodium falciparum
Ursos, L. M. B., & Roepe, P. D. (2002) · Medicinal Research Reviews · doi:10.1002/med.10016 · Cited by 100
Millot, C., Millot, J., Morjani, H., Desplaces, A., & Manfait, M. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500909 · Cited by 100
Zhang, X., Collins, K. I., & Greenberger, L. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5441 · Cited by 116
Mao, Q., Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00150-9 · Cited by 111
Self-citationThe (patho)physiological functions of the MRP family
Renes, J., de Vries, E. G. E., Jansen, P. L. M., & Müller, M. M. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0156 · Cited by 112
Kauffmann, H., KEPPLER, D. O. R., Kartenbeck, J., & Schrenk, D. (1997) · Hepatology · doi:10.1002/hep.510260427 · Cited by 104
Courtois, A., Payen, L. F., Guillouzo, A., & Fardel, O. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01295-8 · Cited by 100
Kuss, B. J., Eyre, H. J., Lane, S. A., Nancarrow, J. K., Whitmore, S. A., Callen, D. F., Deeley, R. G., Cole, S. P. C., Willman, C. L., Kopecky, K., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92938-6 · Cited by 108
Self-citationSpiegl‐Kreinecker, S., Buchroithner, J., Elbling, L., Steiner, E., Wurm, G., Bodenteich, A., Fischer, J., Micksche, M., & Berger, W. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015735815111 · Cited by 99
“All these proteins belong to the superfamily of ATP-binding cassette transporter proteins utilizing ATP for exporting substrate drugs against a concentration gradient [8,9].”
BackgroundDown-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol
Xu, D., Lu, Q., & Hu, X. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.031 · Cited by 99
Sachs, C. W., Safa, A. R., Harrison, S. D., & Fine, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26639 · Cited by 99
Zhu, Q., & M S Center (1994) · PubMed · Cited by 99
MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
Januchowski, R., Wojtowicz, K., Sujka‐Kordowska, P., Andrzejewska, M., & Zabel, M. (2012) · BioMed Research International · doi:10.1155/2013/241763 · Cited by 107
“is gene was �rst described in the non-P-gp MDR small-cell lung carcinoma cell line [12, 17].”
BackgroundGuan, N., Zhao, Y. F., Wang, C.-C., Li, J., Chen, X., & Piao, X. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.017 · Cited by 105
Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections
Sauna, Z. E., Shukla, S., & Ambudkar, S. V. (2005) · Molecular BioSystems · doi:10.1039/b504392a · Cited by 98
The cryptophycins: Their synthesis and anticancer activity
Eggen, M., & Georg, G. I. (2002) · Medicinal Research Reviews · doi:10.1002/med.10002 · Cited by 98
Chittchang, M., Batsomboon, P., Ruchirawat, S., & Ploypradith, P. (2009) · ChemMedChem · doi:10.1002/cmdc.200800339 · Cited by 98
Roles of Multidrug Resistance Genes in Breast Cancer Chemoresistance
Kuo, M. T. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74039-3_2 · Cited by 102
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy
Brinkmann, U., Roots, I., & Eichelbaum, M. F. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01892-x · Cited by 109
Régina, A., Romero, I. A., Greenwood, J., Adamson, P., Bourre, J. M., Couraud, P., & Roux, F. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01954.x · Cited by 98
Mechanism of Action of ABC Importers: Conservation, Divergence, and Physiological Adaptations
Lewinson, O., & Livnat‐Levanon, N. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.01.010 · Cited by 114
Ho, M., Hogge, D. E., & Ling, V. W. T. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.11.014 · Cited by 99
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., & Zintl, F. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03550.x · Cited by 97
“Overexpression of proteins which belong to the adenoside– triphosphate-binding cassette (ABC) superfamily of transporters have been shown as an important cause of cellular drug resistance (Riordan & Ling, 1989; Cole et al, 1992; Sauerbrey et al, 1994; van den Heuvel-Eibrink et al, 2000).”
BackgroundMao, Q., Deeley, R. G., & Cole, S. P. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004584200 · Cited by 97
Self-citationClinical Pharmacokinetics of Vinorelbine
Levêque, D., & Jehl, F. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00003 · Cited by 96
Katzmann, D. J., Epping, E. A., & Moye-Rowley, W. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2998 · Cited by 97
“The identical spacing of these elements in NBD1 of the MRP family serves to define this class of ABC transporter proteins ( 8 ).”
BackgroundInfluentialAnthracyclines in haematology: preclinical studies, toxicity and delivery systems
Richardson, D. S., & Johnson, S. A. (1997) · Blood Reviews · doi:10.1016/s0268-960x(97)90020-5 · Cited by 103
van Brussel, J. P., van Steenbrugge, G. J., Romijn, J. C., Schröder, F. H., & Mickisch, G. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00435-3 · Cited by 101
Courcot, E., Leclerc, J., Lafitte, J., Mensier, E., Jaillard, S. M., Gosset, P., Shirali, P., Pottier, N., Broly, F., & Lo‐Guidice, J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046896 · Cited by 117
“Of these, ABCC1 [multidrug resistance protein 1 (MRP1)] was the first to be characterized (Cole et al., 1992).”
BackgroundMickle, J. E. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.4.729 · Cited by 96
Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.
Wright, S. R., Boag, A. H., Valdimarsson, G., Hipfner, D. R., Campling, B. G., Cole, S. P. C., & Deeley, R. G. (1998) · PubMed · Cited by 111
Self-citationBiochemical and molecular aspects of genetic disorders of bilirubin metabolism
Iyanagi, T., Emi, Y., & Ikushiro, S. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00044-1 · Cited by 104
Sugiyama, Y., Kato, Y., & Chu, X. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051078 · Cited by 95
“[5] found that the multidrug resistance-associated protein (MRP), a member of the ABC transmembrane transport superfamily which has a common ABC”
BackgroundVenkatraman, G., Benesch, M. G. K., Tang, X., Dewald, J. W., McMullen, T. P. W., & Brindley, D. N. (2014) · The FASEB Journal · doi:10.1096/fj.14-262659 · Cited by 96
“Increased expressions of the MDRTs ABCB1 (55), ABCC1 (56), and ABCG2 (57), as well as several antioxidant genes, are implicated in resistance to cancer therapies (58).”
BackgroundInfluentialKamp, D., & Haest, C. W. M. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00049-2 · Cited by 103
Clinical relevance of P-glycoprotein expression in haematological malignancies
Nooter, K., & Sonneveld, P. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90025-6 · Cited by 95
Liao, W., Sohn, Y. S., Riutin, M., Cecconello, A., Parak, W. J., Nechushtai, R., & Willner, I. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600069 · Cited by 95
Stöckel, B., König, J., Nies, A. T., Cui, Y., Brom, M., & KEPPLER, D. O. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01106.x · Cited by 113
Kim, S.-J., Uehara, H., Yazıcı, S., Busby, J. E., Nakamura, T., He, J., Maya, M., Logothetis, C. J., Mathew, P. F., Wang, X., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj211 · Cited by 100
Mollee, H., Steenvoorden, D. P. T., de Vringer, T., & Crommelin, D. J. A. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200105)90:5<617::aid-jps1018>3.0.co;2-5 · Cited by 7
Drug-Induced Liver Injury: Insights from Genetic Studies
Andrade, R. J., Robles, M., Ulzurrun, E., & Lucena, M. I. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.111 · Cited by 94
Introduction: Transport across the hepatocyte canalicular membrane
KEPPLER, D. O. R., & Arias, I. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034161 · Cited by 94
“In addition, cMRP/cMOAT, MRP2 (22, 23) and the multidrug resistance protein, MRP1 (34), are characterized by a hydrophobic amino terminus of about 200 amino acids.”
MRP and MDR1 gene expression in primary breast carcinomas.
Filipits, M., Suchomel, R. W., Dekan, G., Haider, K., Valdimarsson, G., Depisch, D., & Pirker, R. (1996) · PubMed · Cited by 94
Kauffmann, H.-M., & Schrenk, D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8340 · Cited by 93
ATP-Binding Cassette Efflux Transporters in Human Placenta
Ni, Z., & Mao, Q. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164057 · Cited by 112
Hyperthermia: Cancer Treatment and Beyond
Bettaieb, A., Paulina, K., & Diana, A. (2013) · InTech eBooks · doi:10.5772/55795 · Cited by 93
“MRP1 is a 190-kDa member of the ABC transporter family of proteins [122].”
BackgroundKourti, M., Vavatsi, N. A., Gombakis, N., Sidi, V., Tzimagiorgis, G., Papageorgiou, T., Koliouskas, D. E., & Athanassiadou, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.e0624 · Cited by 93
Genetic analysis of the xenobiotic resistance‐associated ABC gene subfamilies of the Lepidoptera
Labbe, R. M., Caveney, S., & Donly, C. (2010) · Insect Molecular Biology · doi:10.1111/j.1365-2583.2010.01064.x · Cited by 93
“1986), the multidrug resistance-associated proteins [MRPs and ABCC (McGrath & Center, 1987; Mirski et al. 1987; Cole et al. 1992)], and the breast cancer resistance protein [BCRP and ABCG2 (Doyle et al.”
BackgroundClinical significance of Y chromosome loss in hematologic disease
Wiktor, A., Rybicki, B. A., Piao, Z. S., Shurafa, M., Barthel, B., Maeda, K., & Van Dyke, D. L. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1<11::aid-gcc2>3.0.co;2-i · Cited by 165
Export pumps for anionic conjugates encoded by MRP genes
KEPPLER, D. O. R., Cui, Y., König, J., Leier, I., & Nies, A. T. (1999) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(98)00015-6 · Cited by 102
Hasegawa, S., Abe, T., Naito, S., Kotoh, S., Kumazawa, J., Hipfner, D. R., Deeley, R. G., Cole, S., & Kuwano, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.177 · Cited by 93
Self-citationMadon, J., Eckhardt, U., Gerloff, T., Stieger, B., & Meier, P. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00245-7 · Cited by 93
Wanke, D., & Kolukisaoglu, H. Ü. (2010) · Plant Biology · doi:10.1111/j.1438-8677.2010.00380.x · Cited by 104
“A few years later, a second ABC transporter, MRP1 (Multidrug Resistance-related Protein 1), with similarities to PGP1 was reported to function as a detoxifier (Cole et al. 1992).”
BackgroundPolymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters
Conseil, G., Deeley, R. G., & Cole, S. P. C. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000167333.38528.ec · Cited by 92
Self-citationReversal of MRP-mediated doxorubicin resistance with quinoline-based drugs.
Vezmar, M., & Georges, E. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00270-7 · Cited by 95
Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2
Boumendjel, A., Macalou, S., Ahmed‐Belkacem, A., Blanc, M., & Pietro, A. D. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.017 · Cited by 92
Expression of multidrug resistance protein gene in patients with glioma chemotherapy
Abe, T., Mori, T., Wakabayashi, Y., Nakagawa, M., Cole, S. P. C., Koike, K., Kuwano, M., & Hori, S. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005954406809 · Cited by 92
Self-citationMultidrug resistance and P-glycoproteins in parasitic protozoa
Ullman, B. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110334 · Cited by 92
The effects of excipients on transporter mediated absorption
Goole, J., Lindley, D. J., Roth, W. J., Carl, S. M., Amighi, K., Kauffmann, J., & Knipp, G. T. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.019 · Cited by 111
Zheng, L.-S., Wang, F., Li, Y.-H., Zhang, X., Chen, L.-M., Liang, Y.-J., Dai, C.-L., Yan, Y.-Y., Tao, L.-Y., Mi, Y.-J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005172 · Cited by 91
“ABCC1, encoded by the ABCC1 gene on chromosome 16p13.1, was first identified from MDR human NSCLC cell line H69/ADR. It can transport a broad-spectrum of substrate anticancer drugs mainly conjugated to glutathione, glucuronate and sulfate, including vincristine and doxorubicin”
BackgroundExtracellular matrix regulation of drug resistance in small-cell lung cancer
Hodkinson, P. S., MacKinnon, A. C., & Sethi, T. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701570204 · Cited by 92
Pesic, M., Markovic, J. Z., Jankovic, D., Kanazir, S., Marković, I., Rakić, L. M., & Ruždijić, S. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.1.66 · Cited by 91
Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes
Mercier, C., Masseguin, C., Roux, F. S., Gabrion, J., & Scherrmann, J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.034 · Cited by 96
Sauna, Z. E., Peng, X.-H., Nandigama, K., Tekle, S., & Ambudkar, S. V. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.675 · Cited by 100
“However, overall, MRP1 has 25 cysteines (Cole et al., 1992), whereas Pgp has only seven cysteine residues (Chen et al., 1986).”
BackgroundZhang, F. Y., Du, G. J., Zhang, L., Zhang, C. L., Lü, W.-L., & Liang, W. P. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9793-y · Cited by 96
Barnouin, K., Leier, I., Jedlitschky, G., Pourtier, A., König, J., Lehmann, W., & KEPPLER, D. O. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.34 · Cited by 101
“The amino acid sequence deduced from this fragment was 88% and 80% identical to and 93% and 88% similar to murine Mrpl (Stride et al, 1996) and human MRP1 (Cole et al, 1992) respectively (Figure 3).”
BackgroundResultAshrafizadeh, M., Zarrabi, A., Saberifar, S., Hashemi, F., Hushmandi, K., Hashemi, F., Moghadam, E. R., Mohammadinejad, R., Najafi, M., & Garg, M. (2020) · Biomedicines · doi:10.3390/biomedicines8050110 · Cited by 99
Chu, X., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., et al. (1998) · PubMed · Cited by 90
Insight in eukaryotic ABC transporter function by mutation analysis
Frelet‐Barrand, A., & Klein, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.024 · Cited by 106
“relatively higher levels found in the lung, testis, kidney, muscle and peripheral blood mononuclear cells [13,14].”
BackgroundRonaldson, P. T., Persidsky, Y., & Bendayan, R. (2008) · Glia · doi:10.1002/glia.20725 · Cited by 90
“Since 1992, when the first MRP/Mrp family members were cloned and characterized (Cole et al., 1992), several anticancer drugs have been identified to be MRP/Mrp substrates including vincristine (MRP1, MRP2, MRP6), etoposide (MRP1-3, MRP6), methotrexate (MRP1-3), daunorubicin (MRP1-2), and cisplatin…”
BackgroundParekh, H. K., Wiesen, K. M., & Simpkins, H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)83383-7 · Cited by 98
Multidrug resistance of cancer cells
Kane, S. E. (1996) · Advances in Drug Research · doi:10.1016/s0065-2490(96)80005-0 · Cited by 95
Ribozyme-mediated reversal of the multidrug-resistant phenotype.
Scanlon, K. J., Ishida, H., & Kashani‐Sabet, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11123 · Cited by 91
(2003) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004342 · Cited by 90
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.